Nancy Mueller, MD
Neurology · Englewood Cliffs, NJNPI 1124164959
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 91 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by Teva Pharmaceuticals USA, Inc. at 50.7% of the total. Reporting peaked in 2021 at $364 and has fallen 67.4% since, to $119 in 2025. That places this record below the midpoint for neurology clinicians in NJ, where the typical reported total is $1,560.
Across 91 payments — averaging $15.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$734
- AbbVie$187
- Neurocrine Biosciences, Inc.$124
- Pfizer$92
- Portola Pharmaceuticals, LLC$50
- Avanir Pharmaceuticals, Inc.$44
- plus $217 from 9 others
What the payments were for
- Food & beverage$1,448100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 47 | $734 |
| AbbVie(2 entities) | 12 | $187 |
| Neurocrine Biosciences, Inc. | 8 | $124 |
| Pfizer | 5 | $92 |
| Portola Pharmaceuticals, LLC | 1 | $50 |
| Avanir Pharmaceuticals, Inc. | 3 | $44 |
| Johnson & Johnson | 3 | $44 |
| AstraZeneca(2 entities) | 3 | $42 |
| Bristol Myers Squibb | 2 | $30 |
| Lilly USA, LLC | 2 | $25 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $17 |
| Biohaven Pharmaceuticals, Inc. | 1 | $15 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
| Biogen | 1 | $15 |
| Alnylam Pharmaceuticals Inc. | 1 | $14 |
How this compares
$1,448 in reported general payments places this provider in the 45th percentile of 521 neurology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Austedo XrDeutetrabenazine | 28 | $163,369 |
| Nurtec OdtRimegepant Sulfate | 37 | $67,681 |
| UbrelvyUbrogepant | 19 | $23,912 |
| Lamotrigine ErLamotrigine | 33 | $15,422 |
| TegretolCarbamazepine | 12 | $5,331 |
| Breo ElliptaFluticasone/Vilanterol | 13 | $4,852 |
| Depakote ErDivalproex Sodium | 13 | $4,356 |
| Dexlansoprazole DrDexlansoprazole | 16 | $3,541 |
| Memantine Hcl | 47 | $3,178 |
| Armour ThyroidThyroid,pork | 39 | $2,984 |
| Memantine Hcl ErMemantine Hcl | 28 | $2,578 |
| Quetiapine Fumarate ErQuetiapine Fumarate | 29 | $2,531 |
| Oseltamivir Phosphate | 20 | $2,293 |
| ValacyclovirValacyclovir Hcl | 12 | $2,218 |
| Donepezil Hcl | 44 | $2,112 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Teva Pharmaceuticals USA, Inc.Austedo Xr | $734 | $163,36928 claims |
| PfizerNurtec Odt | $92 | $67,68137 claims |
| AbbVieUbrelvy, Armour Thyroid | $187 | $26,89758 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 521 neurology providers in New Jersey.
Other neurology in Englewood Cliffs
- Steven BromleyAudubon$1.5M
- Mary Ann PiconeTeaneck$1.5M
- Fiona GuptaOradell$1.1M
- Matthew DavisMiddletown$567K
- Amos KatzEatontown$558K
- Monte PellmarFreehold$429K
- Marcie RabinSummit$387K
- Ashish KapoorBayonne$329K
- Mario VukicHackensack$310K
- Andrew SylvesterBridgewater$296K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.